1 completed. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Myelokathexis: new trials by email Literature Review of Myelokathexis trials Research Report on Myelokathexis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Plerixafor Versus G-CSF in the Treatment of People With WHIM Syndrome Plerixafor, G-CSF - Myelokathexis, Infections | Phase 2 / Phase 3 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 20 | 2014-10-14 | 2026-06-26 |
Agammaglobulinemia (1) · Immunologic Deficiency Syndromes (1) · Infections (1) · Neutropenia (1) · Warts (1)
Agranulocytosis (1) · Blood Protein Disorders (1) · Cytopenia (1) · DNA Virus Infections (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Leukocyte Disorders (1) · Leukopenia (1) · Lymphatic Diseases (1) · Lymphoproliferative Disorders (1) · Papillomavirus Infections (1) · Skin Diseases (1) · Skin Diseases, Infectious (1) · Skin Diseases, Viral (1)
Filgrastim (1) · Granulocyte Colony-Stimulating Factor (1) · plerixafor (1)
National Institute of Allergy and Infectious Diseases (NIAID) (1)
United States (1)